Free Trial
NASDAQ:TXMD

TherapeuticsMD (TXMD) Stock Price, News & Analysis

TherapeuticsMD logo
$1.42 +0.03 (+2.16%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$1.46 +0.04 (+2.82%)
As of 05/2/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TherapeuticsMD Stock (NASDAQ:TXMD)

Key Stats

Today's Range
$1.35
$1.47
50-Day Range
$0.73
$1.42
52-Week Range
$0.70
$2.44
Volume
85,459 shs
Average Volume
155,076 shs
Market Capitalization
$16.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

TXMD MarketRank™: 

TherapeuticsMD scored higher than 20% of companies evaluated by MarketBeat, and ranked 824th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for TherapeuticsMD.

  • Percentage of Shares Shorted

    1.29% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently decreased by 13.42%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    TherapeuticsMD does not currently pay a dividend.

  • Dividend Growth

    TherapeuticsMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.29% of the float of TherapeuticsMD has been sold short.
  • Short Interest Ratio / Days to Cover

    TherapeuticsMD has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in TherapeuticsMD has recently decreased by 13.42%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for TherapeuticsMD this week, compared to 0 articles on an average week.
  • Search Interest

    2 people have searched for TXMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, TherapeuticsMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,803.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.30% of the stock of TherapeuticsMD is held by insiders.

  • Percentage Held by Institutions

    Only 30.74% of the stock of TherapeuticsMD is held by institutions.

  • Read more about TherapeuticsMD's insider trading history.
Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

TXMD Stock News Headlines

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.
See More Headlines

TXMD Stock Analysis - Frequently Asked Questions

TherapeuticsMD's stock was trading at $0.86 on January 1st, 2025. Since then, TXMD stock has increased by 65.1% and is now trading at $1.42.
View the best growth stocks for 2025 here
.

TherapeuticsMD, Inc. (NASDAQ:TXMD) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.05) earnings per share for the quarter. The firm had revenue of $0.55 million for the quarter. TherapeuticsMD had a negative net margin of 207.77% and a negative trailing twelve-month return on equity of 14.08%.

Shares of TherapeuticsMD reverse split on Monday, May 9th 2022. The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that TherapeuticsMD investors own include Voyager Therapeutics (VYGR), Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Marinus Pharmaceuticals (MRNS), AUO (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
11/12/2024
Today
5/03/2025
Next Earnings (Estimated)
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
Employees
420
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-10,280,000.00
Net Margins
-207.77%
Pretax Margin
-251.25%

Debt

Sales & Book Value

Annual Sales
$1.76 million
Price / Cash Flow
N/A
Book Value
$2.77 per share
Price / Book
0.51

Miscellaneous

Free Float
11,267,000
Market Cap
$16.44 million
Optionable
Optionable
Beta
0.95

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TXMD) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners